Vanda Pharmaceuticals Gears Up for Q3 2026 Earnings
All Eyes on Vanda's Upcoming Financial Report In this fast-paced pharmaceutical game, the stakes are higher than your blood pressure after a steak dinner. Vanda Pharmaceuticals (NASDAQ:VNDA) has marked October 28, 2026, as the day to pull back the curtain on their third quarter financials. Expect the suspense to build until the market takes its breath after closing bell...
Continue Reading